Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QNASL in children with seasonal allergic rhinitis
NCT01307319Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Mar 2011
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclomethasone dipropionate in seasonal allergic rhinitis (SAR), sponsored by Teva Pharmaceutical Industries Ltd.. Started Mar 2011; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT01307319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01307319.